[go: up one dir, main page]

ES2126123T3 - Empleo de cineol o mentol para el tratamiento de asma. - Google Patents

Empleo de cineol o mentol para el tratamiento de asma.

Info

Publication number
ES2126123T3
ES2126123T3 ES94918864T ES94918864T ES2126123T3 ES 2126123 T3 ES2126123 T3 ES 2126123T3 ES 94918864 T ES94918864 T ES 94918864T ES 94918864 T ES94918864 T ES 94918864T ES 2126123 T3 ES2126123 T3 ES 2126123T3
Authority
ES
Spain
Prior art keywords
pct
treatment
terpene compounds
sec
effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94918864T
Other languages
English (en)
Inventor
Uwe R Juergens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934319556 external-priority patent/DE4319556C2/de
Priority claimed from DE4319554A external-priority patent/DE4319554C2/de
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2126123T3 publication Critical patent/ES2126123T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PARA LA SUPRESION DE LA LIBERACION DE ACIDO ARAQUIDONICO A PARTIR DE CELULAS HUMANAS ACUMULADORAS DE FOSFOLIPIDOS SE UTILIZAN ETER, CETONA, TIOLO O ALCOHOL DE TERPENO SATURADO MONO O BICICLICO.
ES94918864T 1993-06-13 1994-06-11 Empleo de cineol o mentol para el tratamiento de asma. Expired - Lifetime ES2126123T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19934319556 DE4319556C2 (de) 1993-06-13 1993-06-13 Verwendung von 1,8-Cineol zur entzündungshemmenden Behandlung von steroidpflichtigem Asthma bronchiale
DE4319554A DE4319554C2 (de) 1993-06-13 1993-06-13 Verwendung von Menthol zur peroralen entzündungshemmenden Behandlung von Asthma bronchiale

Publications (1)

Publication Number Publication Date
ES2126123T3 true ES2126123T3 (es) 1999-03-16

Family

ID=25926728

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94918864T Expired - Lifetime ES2126123T3 (es) 1993-06-13 1994-06-11 Empleo de cineol o mentol para el tratamiento de asma.

Country Status (19)

Country Link
US (1) US5889049A (es)
EP (1) EP0654994B1 (es)
JP (1) JPH08500612A (es)
AT (1) ATE173622T1 (es)
AU (1) AU680663B2 (es)
BG (1) BG62474B1 (es)
BR (1) BR9405404A (es)
CA (1) CA2140660A1 (es)
CZ (1) CZ285025B6 (es)
DE (1) DE59407336D1 (es)
DK (1) DK0654994T3 (es)
ES (1) ES2126123T3 (es)
HU (1) HUT69684A (es)
NO (1) NO313814B1 (es)
PL (1) PL308539A1 (es)
RO (1) RO111989B1 (es)
RU (1) RU2161482C2 (es)
SK (1) SK282308B6 (es)
WO (1) WO1994028895A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693654B1 (fr) * 1992-07-20 1994-08-26 Oreal Médicament, notamment immunomodulateur, contenant des enveloppes ou fractions d'enveloppes de bactéries filamenteuses non photosynthétiques et non fructifiantes, et sa préparation.
SE9604751D0 (sv) * 1996-12-20 1996-12-20 Astra Ab New therapy
GB2329583A (en) * 1997-09-25 1999-03-31 Marilyn Rydstrom Use of tea-tree oil for prophylaxis against cystitis
ES2279614T3 (es) 1998-04-16 2007-08-16 Eurovita A/S Nuevas composiciones sinergicas que contienen compuestos aromaticos y terpenoides presentes en alpinia galanga.
US6420435B1 (en) 1999-11-01 2002-07-16 Joe S. Wilkins, Jr. Method for treating gastrointestinal disorders
US6733794B1 (en) * 1999-12-17 2004-05-11 Edward L. Ingram Topical composition for antiseptic and analgesic purposes
US7041706B2 (en) * 2002-04-19 2006-05-09 Wilkins Jr Joe S Method for treating crohn's disease
RU2210357C1 (ru) * 2002-04-26 2003-08-20 Леонова Наталия Сергеевна Ароматический лечебно-профилактический состав доктора леоновой н.с.
US20040087527A1 (en) * 2002-10-31 2004-05-06 Day Brian J. Methods for treatment of thiol-containing compound deficient conditions
US20080221029A1 (en) * 2002-10-31 2008-09-11 Regents Of The University Of Colorado Methods for treatment of thiol-containing compound deficient conditions
US7790762B2 (en) * 2002-10-31 2010-09-07 National Jewish Health Compounds and methods for thiol-containing compound efflux and cancer treatment
US20110257138A1 (en) * 2008-09-04 2011-10-20 Harold Greve Monoterpenes for treating respiratory tract diseases, in particular bronchopulmonary diseases
DE202010007074U1 (de) 2010-05-12 2011-08-12 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Darreichungsformen für Cineol
DE102010022174A1 (de) 2010-05-12 2011-11-17 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Darreichungsformen für Cineol
NO2627673T3 (es) * 2010-10-15 2017-12-23
MX2013009253A (es) * 2011-02-11 2013-12-16 Zx Pharma Llc Formulaciones multiparticuladas de l-mentol y metodos relacionados.
DE202012000910U1 (de) * 2012-01-20 2013-01-21 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Systemische Darreichungsformen mit kontrollierter Freisetzung und verbesserter Stabilität
JP2012131823A (ja) * 2012-03-12 2012-07-12 Lotte Co Ltd 線毛運動活性化剤及びそれを含む飲食品

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4103019A (en) * 1975-10-07 1978-07-25 Laboratorios Landerlan, S. A. Triterpene derivatives
ES537162A0 (es) * 1983-10-31 1985-12-01 Merck Frosst Canada Inc Una composicion farmaceutica
JP2524709B2 (ja) * 1985-09-26 1996-08-14 塩野義製薬株式会社 鎮痛消炎作用増強剤
US5120538A (en) * 1990-02-05 1992-06-09 Pt Darya-Varia Laboratoria Combinations of compounds isolated from curcuma spp as anti-inflammatory agents
US5580562A (en) * 1990-03-14 1996-12-03 Board Of Regents The University Of Texas System Preparations and uses thereof for immunosuppression
US5616458A (en) * 1990-03-14 1997-04-01 Board Of Regents, University Of Tx System Tripterygium wilfordii hook F extracts and components, and uses thereof
AU7570191A (en) * 1990-03-14 1991-10-10 Board Of Regents, The University Of Texas System Tripterygium wilfordii hook f extracts and components thereof for immunosuppression
JPH0426619A (ja) * 1990-05-18 1992-01-29 Lotte Co Ltd 抗アレルギー剤および抗アレルギー剤を含有する食品添加物
WO1992017064A2 (en) * 1991-04-08 1992-10-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inhibitors of protein kinase c function
US5322689A (en) * 1992-03-10 1994-06-21 The Procter & Gamble Company Topical aromatic releasing compositions
US5338758A (en) * 1992-04-03 1994-08-16 Schering Corporation Bicyclic diterpene PAF antagonist compounds
DE4211745A1 (de) * 1992-04-03 1993-10-07 Boerner Gmbh Verwendung von Propolis und/oder seinen Fraktionen
US5527890A (en) * 1993-04-16 1996-06-18 Glycomed Incorporated Derivatives of triterpenoid acids and uses thereof
US5464754A (en) * 1993-08-17 1995-11-07 The Regents Of The University Of California Assay and substrate for arachidonoyl-specific phospholipase A2
US5665386A (en) * 1995-06-07 1997-09-09 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds

Also Published As

Publication number Publication date
SK30395A3 (en) 1995-11-08
NO950518L (no) 1995-02-10
DK0654994T3 (da) 1999-08-09
HU9500714D0 (en) 1995-04-28
AU7000394A (en) 1995-01-03
RU2161482C2 (ru) 2001-01-10
NO950518D0 (no) 1995-02-10
SK282308B6 (sk) 2002-01-07
HUT69684A (en) 1995-09-28
AU680663B2 (en) 1997-08-07
WO1994028895A2 (de) 1994-12-22
BR9405404A (pt) 1999-05-25
DE59407336D1 (de) 1999-01-07
US5889049A (en) 1999-03-30
CA2140660A1 (en) 1994-12-22
EP0654994B1 (de) 1998-11-25
EP0654994A1 (de) 1995-05-31
BG99499A (bg) 1995-12-29
BG62474B1 (bg) 1999-12-30
CZ285025B6 (cs) 1999-05-12
RO111989B1 (ro) 1997-04-30
WO1994028895A3 (de) 1995-04-06
ATE173622T1 (de) 1998-12-15
JPH08500612A (ja) 1996-01-23
PL308539A1 (en) 1995-08-21
CZ37095A3 (en) 1995-11-15
NO313814B1 (no) 2002-12-09

Similar Documents

Publication Publication Date Title
ES2126123T3 (es) Empleo de cineol o mentol para el tratamiento de asma.
DK0682514T3 (da) Anvendelse af lokalanæstetiske midler til fremstilling af et lægmiddel til behandling af bronchial astma
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
PT671910E (pt) Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
CY1107262T1 (el) Θεραπεια της εξαρτησης στερησης
JP2004507496A5 (es)
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
CO5570661A2 (es) Combinaciones que comprenden inhibidores de cox-2 y aspirina
KR910005858A (ko) 지방산 요법
DK0714304T3 (da) Terapeutisk system til behandling af psoriasis
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
NO20042758L (no) Fremgangsmate for behandling av en pasient som krever analgesi.
ES2038716T3 (es) Metodos y composiciones para el tratamiento de la psoriasis.
ES2095086T3 (es) Metodo para el tratamiento y la prevencion de la obesidad.
AR003979A1 (es) Administracion transdermica de vorozol.
HUP9801628A2 (hu) Artritisz elleni gyógyászati készítmények
AR002968A1 (es) Uso de hirudina y acido acetilsalicilico para la preparacion de un medicamento para tratar un infarto de miocardio agudo en pacientes nosometidos a tratamiento trombolitico y una composicion farmaceutica.
MD3381G2 (ro) Metodă de tratament al parotiditei cronice la copii
AR004034A1 (es) Composicion farmaceutica para la profilaxis o terapia de la artritis y su uso
UA36361A (uk) Спосіб лікування захворювань щитовидної залози
UA37528A (uk) Спосіб профілактики післяопераційних ускладнень у дітей після тонзилектомії
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 654994

Country of ref document: ES